Role of protein kinase D signaling in pancreatic cancer
- PMID: 20621068
- PMCID: PMC2974013
- DOI: 10.1016/j.bcp.2010.07.002
Role of protein kinase D signaling in pancreatic cancer
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with dismal survival rates. Its intransigence to conventional therapy renders PDAC an aggressive disease with early metastatic potential. Thus, novel targets for PDAC therapy are urgently needed. Multiple signal transduction pathways are implicated in progression of PDAC. These pathways stimulate production of intracellular messengers in their target cells to modify their behavior, including the lipid-derived diacylglycerol (DAG). One of the prominent intracellular targets of DAG is the protein kinase C (PKC) family. However, the mechanisms by which PKC-mediated signals are decoded by the cell remain incompletely understood. Protein kinase D1 (PKD or PKD1, initially called atypical PKCμ), is the founding member of a novel protein kinase family that includes two additional protein kinases that share extensive overall homology with PKD, termed PKD2, and PKD3. The PKD family occupies a unique position in the signal transduction pathways initiated by DAG and PKC. PKD lies downstream of PKCs in a novel signal transduction pathway implicated in the regulation of multiple fundamental biological processes. We and others have shown that PKD-mediated signaling pathways promote mitogenesis and angiogenesis in PDAC. Our recent observations demonstrate that PKD also potentiates chemoresistance and invasive potential of PDAC cells. This review will briefly highlight diverse biological roles of PKD family in multiple neoplasias including PDAC. Further, this review will underscore our latest advancement with the development of a potent PKD family inhibitor and its effect both in vitro and in vivo in PDAC.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdad/2974013/7e80d883d472/nihms222722f1.gif)
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdad/2974013/4a2bbbf3a110/nihms222722f2.gif)
Similar articles
-
Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells.J Cell Physiol. 2011 Apr;226(4):1074-81. doi: 10.1002/jcp.22421. J Cell Physiol. 2011. PMID: 20857418
-
A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo.Mol Cancer Ther. 2010 May;9(5):1136-46. doi: 10.1158/1535-7163.MCT-09-1145. Epub 2010 May 4. Mol Cancer Ther. 2010. PMID: 20442301 Free PMC article.
-
PKD, PKD2, and p38 MAPK mediate Hsp27 serine-82 phosphorylation induced by neurotensin in pancreatic cancer PANC-1 cells.J Cell Biochem. 2008 Feb 1;103(2):648-62. doi: 10.1002/jcb.21439. J Cell Biochem. 2008. PMID: 17570131
-
PKD at the crossroads of DAG and PKC signaling.Trends Pharmacol Sci. 2006 Jun;27(6):317-23. doi: 10.1016/j.tips.2006.04.003. Epub 2006 May 6. Trends Pharmacol Sci. 2006. PMID: 16678913 Review.
-
Kinase signaling pathways as targets for intervention in pancreatic cancer.Cancer Biol Ther. 2010 May 15;9(10):754-63. doi: 10.4161/cbt.9.10.11534. Cancer Biol Ther. 2010. PMID: 20234186 Review.
Cited by
-
Detection of differentially expressed candidate genes for a fatty liver QTL on mouse chromosome 12.BMC Genet. 2016 Jun 6;17(1):73. doi: 10.1186/s12863-016-0385-2. BMC Genet. 2016. PMID: 27266874 Free PMC article.
-
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma.BMC Cancer. 2018 Nov 12;18(1):1107. doi: 10.1186/s12885-018-4965-6. BMC Cancer. 2018. PMID: 30419840 Free PMC article.
-
Analysis of catechol-O-methyltransferase gene mutation and identification of new pathogenic gene for paroxysmal kinesigenic dyskinesia.Neurol Sci. 2016 Mar;37(3):377-83. doi: 10.1007/s10072-015-2432-6. Epub 2015 Dec 9. Neurol Sci. 2016. PMID: 26650803
-
Multifaceted Functions of Protein Kinase D in Pathological Processes and Human Diseases.Biomolecules. 2021 Mar 23;11(3):483. doi: 10.3390/biom11030483. Biomolecules. 2021. PMID: 33807058 Free PMC article. Review.
-
The involvement of specific PKC isoenzymes in phorbol ester-mediated regulation of steroidogenic acute regulatory protein expression and steroid synthesis in mouse Leydig cells.Endocrinology. 2011 Jan;152(1):313-25. doi: 10.1210/en.2010-0874. Epub 2010 Nov 3. Endocrinology. 2011. PMID: 21047949 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin. 2009;59:225–249. - PubMed
-
- Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437–450. - PubMed
-
- Maitra A, Fukushima N, Takaori K, Hruban RH. Precursors to invasive pancreatic cancer. Adv Anat Pathol. 2005;12:81–91. - PubMed
-
- Brand RE, Tempero MA. Pancreatic cancer. Curr Opin Oncol. 1998;10:362–366. - PubMed
-
- Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20:1218–1249. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 CA016672/CA/NCI NIH HHS/United States
- R21CA135218/CA/NCI NIH HHS/United States
- 5P30CA16672/CA/NCI NIH HHS/United States
- R21CA137292/CA/NCI NIH HHS/United States
- R01 DK056930/DK/NIDDK NIH HHS/United States
- P30 DK041301/DK/NIDDK NIH HHS/United States
- R01DK56930/DK/NIDDK NIH HHS/United States
- R21 CA135218/CA/NCI NIH HHS/United States
- P30 DK041301-22/DK/NIDDK NIH HHS/United States
- R01 DK055003-13/DK/NIDDK NIH HHS/United States
- R21 CA137292/CA/NCI NIH HHS/United States
- R01 DK055003/DK/NIDDK NIH HHS/United States
- P30DK41301/DK/NIDDK NIH HHS/United States
- R01DK55003/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous